Characteristic | N | % |
---|---|---|
Age | ||
<50 | 24 | 24 % |
50-59 | 23 | 23 % |
>60 | 53 | 53 % |
Histology | ||
DCI | 75 | 75 % |
LCI | 15 | 15 % |
Others | 10 | 10 % |
Pathological tumor stage | ||
pTis | 2 | 2 % |
pT1 | 51 | 51 % |
pT2 | 38 | 38 % |
pT3 | 2 | 2 % |
pT4 | 2 | 2 % |
Not evaluable | 5 | 5 % |
Pathological nodal stage | ||
pN0 | 9 | 9 % |
pN1 | 25 | 25 % |
pN2 | 43 | 43 % |
pN3 | 23 | 23 % |
Grading | ||
G1 | 4 | 4 % |
G2 | 54 | 54 % |
G3 | 38 | 38 % |
Not evaluable | 4 | 4 % |
Ki67 | ||
≤14 % | 27 | 27 % |
>14 % | 71 | 71 % |
Not evaluated | 2 | 2 % |